Similarly, Du et al1162 suggest that TRPML1 small molecule activation induces Zn2+ release mediated cell death in metastatic melanoma, emphasizing that instead of inhibition, activation of TRPML1 may be beneficial in treating metastasis formation in cancer, at least in melanoma. The gene discussed is MCOLN1; the disease is metastatic melanoma.